Peripheral neuropathy during longterm high-dose amiodarone therapy.
Open Access
- 1 June 1985
- journal article
- case report
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 48 (6), 576-578
- https://doi.org/10.1136/jnnp.48.6.576
Abstract
Three patients developed peripheral neuropathy after taking amiodarone for more than 18 months. All had high serum concentrations of amiodarone and its desethyl metabolite; in one patient concentrations in a sural nerve biopsy were 80 times higher than in serum. Peripheral neuropathy is a complication of large doses of amiodarone taken over long periods.This publication has 16 references indexed in Scilit:
- Neuropathy and fatal hepatitis in a patient receiving amiodarone.BMJ, 1984
- Peripheral neuropathy induced by amiodarone chlorhydrate: A clinicopathological studyJournal of the Neurological Sciences, 1984
- High-performance liquid chromatographic measurement of amiodarone and desethylamiodarone in small tissue samples after enzymatic digestion.Journal of Clinical Pathology, 1983
- Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias.Circulation, 1983
- Amiodarone neuropathyNeurology, 1983
- High-Performance Liquid Chromatographic Measurement of Amiodarone and Its Desethyl MetaboliteTherapeutic Drug Monitoring, 1982
- Amiodaron Neuropathy: Further Arguments for Human Drug-Induced NeurolipidosisEuropean Neurology, 1982
- Neuromyopathy during chronic amiodarone treatment. A case report.1979
- Neuromyopathy during chronic amiodarone treatmentZeitschrift für Neurologie, 1979
- AMIODARONE AND NEUROLOGICAL SIDE-EFFECTSThe Lancet, 1974